Skip to main content
2026 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Vibha Jawa, PhD, FAAPS (she/her/hers)

Chief Scientific Officer
EpiVax, Inc.
Providence, Rhode Island

Vibha Jawa, PhD, FAAPS
Chief Scientific Officer, EpiVax Inc.

Dr. Vibha Jawa is Chief Scientific Officer of EpiVax, where she leads scientific strategy, guiding research efforts and shaping the company’s approach to new therapies and technologies. Previously, she was Executive Director in the Translational Medicine organization at Bristol Myers Squibb, where she led the biotherapeutic and cell/gene therapy bioanalytical function, supporting PK and immunogenicity in preclinical and clinical development. Vibha also led the Predictive and Clinical Immunogenicity group at Merck and spent 14 years at Amgen supporting Discovery to Development for biotherapeutics. With over 20 years of experience in biologics, vaccines, and gene therapy, she has contributed to 20+ IND, BLA, and MAA filings. A recognized leader in Bioanalysis and Immunogenicity, Vibha has 75+ peer-reviewed publications and serves as a Reviewer and Editor for The AAPS Journal and J. Pharm Sci. She is active in multiple scientific societies (IQ, SC space Consortium, and EIP) and holds leadership roles within AAPS, including Track Chair of the Land O' Lakes Bioanalysis Meeting and Chair of the Cell and Gene Therapy Bioanalysis and Biomarker Working Group. She was named an AAPS Fellow in 2022.

Disclosure information not submitted.

Presentation(s):